The COVID-19 pandemic has transformed healthcare systems around the world. One of important issues that COVID-19 clearly emphasizes is the critical importance of information on health technology and policy. Handling the COVID-19 pandemic was difficult at the beginning because humanity all faced the

My name is Manilung Nalongsack. I am from Laos and work for Lao-Oxford-Mahosod Hospital- Wellcome Trust Research Unit. I have been doing a one-year internship at Health Intervention and Technology Assessment Program (HITAP) since September 2022. Before I joined HITAP, I had two interests, including

In a constantly evolving world of healthcare, staying updated and informed about new developments and innovations is essential. The Health Intervention and Technology Assessment Program (HITAP), a Health Technology Assessment (HTA) organisation in the Ministry of Public Health, Thailand, had the opp

Beijing Children’s Hospital, Capital Medical University, National Centre for Children’s Health of China are committed to advancing skills in conducting comprehensive clinical evaluations of medicines. This commitment is evident through a variety of initiatives, including workshops, training, and aca

India has established Health Technology Assessment (HTA) to increase the use of evidence in informing health policy decisions. The Post-Graduate Institute of Medical Education and Research (PGIMER), a resource hub for HTA and a leading public health institution in India, hosted a workshop titled “Co

The rapid advancement of technology is reshaping global health, offering new opportunities to strengthen health systems. The Prince Mahidol Award Conference (PMAC) 2025, under the theme of “Harnessing Technologies in an Age of AI to Build a Healthier World,” provided invaluable insights into the com

At the recent Prince Mahidol Award Conference (PMAC) 2025, the Health Intervention and Technology Assessment Program (HITAP) Foundation hosted a side meeting on the role of artificial intelligence (AI) in healthcare. This meeting “Is AI a Panacea for the Health Sector? Navigating the Barriers to Ado

The Food and Drug Administration has agreed to give priority status to its review of three new uses for the anticlotting drug Xarelto, Johnson & Johnson announced Monday.The company is asking the agency to approve the drug to treat deep vein thrombosis and pulmonary embolism, and to prevent recu

(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E

Wales’ health minister says it was “entirely appropriate” for her civil servants to be in contact with the author of a report into the NHS.Lesley Griffiths defended emails between senior officials and the academic behind the report.Officials were also challenged about why local health boards thought